Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126643411 | 12664341 | 1 | I | 20160815 | 20160818 | 20160818 | EXP | GB-JNJFOC-20160813065 | JANSSEN | 0.00 | M | Y | 0.00000 | 20160818 | CN | GB | GB |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126643411 | 12664341 | 1 | PS | DOXORUBICIN HYDROCHLORIDE. | DOXORUBICIN HYDROCHLORIDE | 1 | Unknown | 8 ROUNDS | U | U | 50718 | LIPOSOME INJECTION | |||||||
| 126643411 | 12664341 | 2 | SS | PREDNISOLONE. | PREDNISOLONE | 1 | Unknown | U | 0 | UNSPECIFIED | |||||||||
| 126643411 | 12664341 | 3 | SS | RITUXIMAB | RITUXIMAB | 1 | Unknown | EVERY 2 MONTHS | U | 0 | UNSPECIFIED | ||||||||
| 126643411 | 12664341 | 4 | SS | CYCLOPHOSPHAMIDE. | CYCLOPHOSPHAMIDE | 1 | Unknown | U | 0 | UNSPECIFIED | |||||||||
| 126643411 | 12664341 | 5 | SS | VINCRISTINE | VINCRISTINE | 1 | Unknown | U | 0 | UNSPECIFIED |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126643411 | 12664341 | 1 | Follicle centre lymphoma, follicular grade I, II, III |
| 126643411 | 12664341 | 2 | Follicle centre lymphoma, follicular grade I, II, III |
| 126643411 | 12664341 | 3 | Follicle centre lymphoma, follicular grade I, II, III |
| 126643411 | 12664341 | 4 | Follicle centre lymphoma, follicular grade I, II, III |
| 126643411 | 12664341 | 5 | Follicle centre lymphoma, follicular grade I, II, III |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 126643411 | 12664341 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126643411 | 12664341 | Follicle centre lymphoma, follicular grade I, II, III recurrent | |
| 126643411 | 12664341 | Mass | |
| 126643411 | 12664341 | Off label use | |
| 126643411 | 12664341 | Product use issue |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 126643411 | 12664341 | 1 | 20151224 | 0 | ||
| 126643411 | 12664341 | 2 | 20151224 | 0 | ||
| 126643411 | 12664341 | 4 | 20151224 | 0 | ||
| 126643411 | 12664341 | 5 | 20151224 | 0 |